Skip to content

Golden Eagle Dynamic Hypergrowth ETF

HYPNasdaqD

$29.32+0.06 (+0.19%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: up, 17 prints from 29.26 to 29.32. Range 28.79 to 29.32. Use the arrow keys to read each point.28.8028.9029.0029.1010 AM12 PM2 PM4 PM
Expense ratio
0.85%
Fund size
$38M
1Y total return
+18.5%
Yield · Last 12 months
Data unavailable
Holdings
61
Avg volume · 30D
0M sh
NAV per share
$29.83
52W range
low $21.06high $32.16
Launched

The ETF.net HYP Grade

D

Score 37 out of 100

Rank
69 of 90
Six-pillar profile for HYP. Scores out of 100: Cost 13, Risk 17, Mission 18, Tradability 75, Holdings 89, Durability 33. Strongest: Holdings (89). Weakest: Cost (13). Leans toward Holdings.

Score 37 of 100 falls in the D band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    F13 out of 100
    Rank 77 of 90
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    F18 out of 100
    Rank 26 of 27
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    F17 out of 100
    Rank 78 of 82
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    A75 out of 100
    Rank 6 of 90
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A89 out of 100
    Rank 2 of 89
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    D33 out of 100
    Rank 76 of 90

Our read on HYP

ETF.net Research

DAn active US growth fund that launched in 2006, a decade before active ETFs became fashionable. Plain wrapper, in-house stock-picking model, and a fee well above the quant-run newcomers now crowding the same lane.

Stated mandate

The Fund seeks capital appreciation.

Why people hold it

  1. 01Launched in 2006, when active ETFs were still a curiosity. It has run a US growth book through the financial crisis, the 2010s melt-up, and the 2022 reset.
  2. 02The portfolio is the strongest part of the package: straightforward US-listed stocks inside a standard 1940 Act fund, with no offshore or partnership plumbing to decode.
  3. 03One job, stated plainly: capital appreciation from US stocks chosen by a proprietary growth model. No sector sleeves, no index to hug.

Worth knowing

  1. 01The 0.85% annual fee sits above what most active US growth ETFs charge, including quant-driven peers like JUSA (0.12%) and FELG (0.18%) fishing in the same pond.
  2. 02Small asset base and thin trading. The price on screen can drift further from the portfolio's value than it would in a heavily traded peer, so the order type you use matters.
  3. 03The name sets a high bar. In practice the book has read closer to mainstream US growth than the 'hypergrowth' billing implies, and it has been a volatile ride.

HYP Holdings

As of Oct 12, 2026
Asset class
Stocks
Holdings
61
Top-10 weight
27%
Largest holding
PENG3.4%

Geography

  • United States82.77%
  • Singapore4.22%
  • Bermuda3.34%
  • Taiwan (Province of China)3.21%
  • Canada2.08%
  • Cyprus1.16%
  • Greece1.13%
  • United Kingdom1.09%
  • Other countries (1)1.00%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001PENGPenguin Solutions Inc3.41%17,055$1M116
002LITELumentum Holdings Inc2.82%975$1M403
003AAOIApplied Optoelectronics Inc2.73%9,505$1M99
004VIAVViavi Solutions Inc2.71%22,764$1M148
005OSCROscar Health Inc. Class A2.65%30,278$1M133
006MXLMaxlinear Inc-Class A2.64%10,470$1M129
007DELLDell Technologies - Class C2.63%1,714$1M443
008PBFPbf Energy Inc-Class A2.61%11,844$998K163
009IBRXImmunitybio Inc2.59%94,231$990K79
010HNGEHinge Health Inc-A2.57%9,525$980K113
011ETONEton Pharmaceuticals Inc2.55%17,613$972K72
012MTRNMaterion Corp2.53%3,449$967K138
013KOSKosmos Energy Ltd2.51%363,513$960K78
014CDNACaredx Inc2.45%14,722$937K111
015BEBloom Energy Corp. Class A2.45%3,331$934K335

Showing 1–15 of 61 holdings

HYP Performance

Launched Sep 23, 2025

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.Not enough history yet.Not enough history yet.
HYP$11,852
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. HYP $11,852. SPY $12,044. Use the arrow keys to read each point.$8,242$10,781$13,320Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for HYP. Periods over one year show the average yearly return.
PeriodHYP
Year to date+24.7%
1 month+7.2%
3 months+0.7%
1 year+18.5%
3 yearsFund is under 3 years oldper year—
5 yearsFund is under 5 years oldper year—
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for HYP
YearReturn barHYP
2026 YTD+24.7%
2025−5.0%

Since listing, Sep 23, 2025

HYP in the news

Filtered to HYP · US Active Growth

HYP Dividends

Last payment
$0.03 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Irregular

Distribution data unavailable.

Distribution history

2025–2026

One bar per payment. 1 payment from 2025 to 2026 YTD. Dec 24, 2025 $0.03. Use the arrow keys to read each point.20252026YTD
Ex-datePay dateAmount per share
Dec 24, 2025Dec 26, 2025$0.03

HYP Risk

How much the fund’s monthly returns vary, scaled to a year.
35.9%
Annualised · 12 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.53
vs 3-month T-bills · 12 months to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−28.8%
12 months · trough Jul 2026
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.44
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

HYP Cost

Expense ratio0.85%
  • The middle half of US Active Growth funds
  • Median 0.56%

76 of the 90 US Active Growth funds charge less.

HYP costs $85.00 a year on $10,000. The median US Active Growth fund costs $56.50.

Other funds in US Active Growth